Klinikum rechts der Isar

Hospital


Location: München, Germany (DE) DE

ISNI: 0000000404772438

ROR: https://ror.org/04jc43x05

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Bridging glucose metabolism and intrinsic functional organization of the human cortex (2026) Wan B, Riedl V, Castrillon G, Kirschner M, Valk SL Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial (2026) Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, et al. Journal article Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases (2026) Landt C, Held F, Kolotourou K, Guranda M, Vakrakou AG, Franz J, Thomas C, et al. Journal article Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness (2026) Pan L, Li C, Moog P, Knoedler S, Kükrek H, Dornseifer U, Machens HG, Jiang J Journal article O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial (2026) Grosu AL, Weber WA, Graf E, Mix M, Nestle U, Schimek-Jasch T, Wiehle R, et al. Journal article ACTN4 p.Ile150Met Causes FSGS With Validation in Primary Fibroblasts and Immortalized Podocytes (2026) Grosch M, Haak J, Kolb C, Plogmann I, Guaragna MS, Wiesener A, Pasutto F, et al. Journal article Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney (2026) Loderbauer L, Knaup K, Reisenbüchler D, Kaiser N, Naas S, Schneider K, Wopperer FJ, et al. Journal article Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). (2026) Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, et al. Journal article Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life (2026) Wurschi GW, Hinz A, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, et al. Journal article